Cost-effectiveness analysis of baseline testing for resistance-associated polymorphisms to optimise treatment outcome in genotype 1 non-cirrhotic treatment-naïve patients with chronic hepatitis c virus

Christopher Fawsitt, Peter Vickerman, Graham S Cooke, Nicky J Welton

Research output: Contribution to journalArticle (Academic Journal)

4 Downloads (Pure)
Original languageEnglish
JournalValue in Health
DOIs
Publication statusPublished - 27 Aug 2019

Cite this